134 related articles for article (PubMed ID: 18984256)
1. Chromosomal imbalances are associated with increased proliferation and might contribute to bone destruction in cholesteatoma.
Ecsedi S; Rákosy Z; Vízkeleti L; Juhász A; Sziklai I; Adány R; Balázs M
Otolaryngol Head Neck Surg; 2008 Nov; 139(5):635-40. PubMed ID: 18984256
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of c-MYC status in primary acquired cholesteatoma by using fluorescence in situ hybridization technique.
Ozturk K; Yildirim MS; Acar H; Cenik Z; Keles B
Otol Neurotol; 2006 Aug; 27(5):588-91. PubMed ID: 16868505
[TBL] [Abstract][Full Text] [Related]
3. Elevated level of tenascin and matrix metalloproteinase 9 correlates with the bone destruction capacity of cholesteatomas.
Juhász A; Sziklai I; Rákosy Z; Ecsedi S; Adány R; Balázs M
Otol Neurotol; 2009 Jun; 30(4):559-65. PubMed ID: 19395987
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of Ki-67 and telomerase activity in middle ear cholesteatoma.
Kuczkowski J; Pawelczyk T; Bakowska A; Narozny W; Mikaszewski B
Otol Neurotol; 2007 Feb; 28(2):204-7. PubMed ID: 17255888
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activity and cell proliferation index in cholesteatoma.
Lee SH; Jang YH; Tae K; Park YW; Kang MJ; Kim KR; Park CW
Acta Otolaryngol; 2005 Jul; 125(7):707-12. PubMed ID: 16012031
[TBL] [Abstract][Full Text] [Related]
6. [Comparative analysis of the proliferative capacity of cholesteatomas].
Bernal Sprekelsen M; Ebmeyer J; Buchbinder A; Sudhoff H
Acta Otorrinolaringol Esp; 2000 May; 51(4):299-307. PubMed ID: 10984952
[TBL] [Abstract][Full Text] [Related]
7. [Epithelium-stroma interaction in cholesteatoma of the middle ear].
Jacob R; Welkoborsky HJ; Mann W
Laryngorhinootologie; 2001 Jan; 80(1):11-7. PubMed ID: 11272241
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of epithelial proliferation in paediatric and adult cholesteatomas using the Ki-67 proliferation marker.
Sikka K; Sharma SC; Thakar A; Dattagupta S
J Laryngol Otol; 2012 May; 126(5):460-3. PubMed ID: 22166746
[TBL] [Abstract][Full Text] [Related]
9. Structural changes and protein expression in the mastoid bone adjacent to cholesteatoma.
Cinamon U; Kronenberg J; Benayahu D
Laryngoscope; 2000 Jul; 110(7):1198-203. PubMed ID: 10892696
[TBL] [Abstract][Full Text] [Related]
10. Aggressiveness and quantification of epithelial proliferation of middle ear cholesteatoma by MIB1.
Mallet Y; Nouwen J; Lecomte-Houcke M; Desaulty A
Laryngoscope; 2003 Feb; 113(2):328-31. PubMed ID: 12567091
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications.
Albino AP; Reed JA; Bogdany JK; Sassoon J; Desloge RB; Parisier SC
Am J Otol; 1998 Jan; 19(1):30-6. PubMed ID: 9455944
[TBL] [Abstract][Full Text] [Related]
12. [Evaluation of Ki-67 expression in recurrent cases of cholesteatoma].
Sanli A; Tezer I; Paksoy M; Aydin S; Hardal U; Ozdemir NB
Kulak Burun Bogaz Ihtis Derg; 2007; 17(2):65-9. PubMed ID: 17527055
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 8 aneuploidy in acquired cholesteatoma.
Yildirim MS; Ozturk K; Acar H; Arbag H; Ulku CH
Acta Otolaryngol; 2003 Apr; 123(3):372-6. PubMed ID: 12737293
[TBL] [Abstract][Full Text] [Related]
14. Nucleoplasm staining patterns and cell cycle-associated expression of Ki-67 in middle ear cholesteatoma.
Raynov AM; Moon SK; Choung YH; Hong SP; Park K
Am J Otolaryngol; 2005; 26(5):296-301. PubMed ID: 16137526
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of ErbB-2 protein in human middle ear cholesteatomas.
Sakamoto T; Kondo K; Yamasoba T; Suzuki M; Sugasawa M; Kaga K
Laryngoscope; 2004 Nov; 114(11):1988-91. PubMed ID: 15510028
[TBL] [Abstract][Full Text] [Related]
16. DNA analysis of human cholesteatomas.
Desloge RB; Carew JF; Finstad CL; Steiner MG; Sassoon J; Levenson MJ; Staiano-Coico L; Parisier SC; Albino AP
Am J Otol; 1997 Mar; 18(2):155-9. PubMed ID: 9093669
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of peroxidase proliferator-activated receptor gamma in cholesteatoma.
Hwang SJ; Kang HJ; Song JJ; Kang JS; Woo JS; Chae SW; Lee HM
Laryngoscope; 2006 Jan; 116(1):58-61. PubMed ID: 16481810
[TBL] [Abstract][Full Text] [Related]
18. Some markers of proliferative activity in cholesteatoma epithelium in adults.
Olszewska E; Chodynicki S; Chyczewski L; Rogowski M
Med Sci Monit; 2006 Aug; 12(8):CR337-40. PubMed ID: 16865065
[TBL] [Abstract][Full Text] [Related]
19. Correlation of clinical and surgical findings to histological features (koilocytosis, papillary hyperplasia) suggesting papillomavirus involvement in the pathogenesis of cholesteatoma.
Ferekidis E; Nikolopoulos TP; Yiotakis J; Ferekidou E; Kandiloros D; Papadimitriou K; Tzangaroulakis A
Med Sci Monit; 2006 Sep; 12(9):CR368-71. PubMed ID: 16940929
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of attic cholesteatoma: clinical and immunohistochemical support for combination of retraction theory and proliferation theory.
Sudhoff H; Tos M
Am J Otol; 2000 Nov; 21(6):786-92. PubMed ID: 11078064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
